Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoproliferative Disorders × Vemurafenib × 90 days × Clear all

Sponsor

Conditions

Neoplasms 3 Melanoma 3 Lymphoma, Non-Hodgkin 3 Skin Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Leukemia, Hairy Cell 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Skin Diseases 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Medulloblastoma 1 Leukemia 1 Histiocytosis, Langerhans-Cell 1 Histiocytic Sarcoma 1 Hepatoblastoma 1 Glioma 1 Ependymoma 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma, Follicular 1

Interventions

fludarabine 4 Cyclophosphamide 4 fludarabine phosphate 3 Tacrolimus 3 Mycophenolic Acid 3 Busulfan 3 venetoclax 2 Whole-Body Irradiation 2 Rituximab 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mesna 2 Melphalan 2 Bortezomib 2 trametinib 1 liposomal doxorubicin 1 isatuximab 1 dabrafenib 1 Zidovudine 1 Vincristine 1 Valganciclovir 1 Thiotepa 1 Specimen Handling 1 Sirolimus 1 Prednisone 1 Nivolumab 1 Lenalidomide 1 Interferon-alpha 1 Granulocyte Colony-Stimulating Factor 1 Genetic Testing 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡